Recombinant human bone morphogenetic protein-2 promote and stabilize hard and soft tissue healing for large mandibular new bone reconstruction defects

Journal of Craniofacial Surgery

Volumn 25, Issue 3, 2014, Pages 860-862

  Cicciù, Marco ^a   Scott, Alan ^b   Cicciù, Domenico ^a   Tandon, Rahul ^b   Maiorana, Carlo ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b LOMA LINDA UNIVERSITY   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Ameloblastoma; Bone regeneration; rhBMP2

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DRUG CARRIER; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALLOGRAFT; AMELOBLASTOMA; BIODEGRADABLE IMPLANT; BONE DEVELOPMENT; BONE REGENERATION; CASE REPORT; DEVICES; DRUG EFFECTS; FOLLOW UP; HUMAN; MALE; MANDIBLE RECONSTRUCTION; MANDIBULAR NEOPLASMS; PLASTIC SURGERY; PROCEDURES; SURGICAL MESH; TRANSPLANTATION;

ABSORBABLE IMPLANTS; ADULT; ALLOGRAFTS; AMELOBLASTOMA; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; COLLAGEN; DRUG CARRIERS; FOLLOW-UP STUDIES; HUMANS; MALE; MANDIBULAR NEOPLASMS; MANDIBULAR RECONSTRUCTION; OSTEOGENESIS; RECOMBINANT PROTEINS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL MESH; TRANSFORMING GROWTH FACTOR BETA;

EID: 84900795376     PISSN: 10492275     EISSN: 15363732     Source Type: Journal    
DOI: 10.1097/SCS.0000000000000830     Document Type: Article

References (15)

1. Misch CM. Comparison of intraoral donor sites for onlay grafting prior to implant placement. Int J Oral Maxillofac Implants 1997;767-776
2. Cicciù M, Herford AS, Stoffella E, et al. Protein-signaled guided bone regeneration using titanium mesh and rhBMP2 in oral surgery: A case involving left mandibular reconstruction after tumor resection. Open Dent J 2012;51-55
3. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005; 1693-1707
4. Triplett RG, Nevins M, Marx R, et al. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009; 1947-1960
5. Fonseca RJ, Barber H, Frost DE, et al. Osseous reconstruction. In: Fonseca, Davis, eds. Reconstructive Preprosthetic Oral and Maxillofacial Surgery. Philadelphia, PA: WB Saunders, 1995:821-852
6. Urist MR. Bone. Formation by autoinduction. Science 1965;893-899
7. Jovanovic SA, Hunt DR, Bernard GW, et al. Long term functional loading of dental implants in rhBMP-2 induced bone. A histological study in the canine ridge augmentation model. Clin Oral Implants Res 2003;793-803
8. Cicciù M, Herford AS, Juodžbalys G, et al. Recombinant human morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw. J Craniofac Surg 2012;784-788
9. Herford AS, Lu M, Akin L, et al. Evaluation of a porcine matrix with and without platelet-derived growth factor for bone graft coverage in pigs. Int J Oral Maxillofac Implants 2012;1351-1358
10. Herford AS, Cicciù M. Recombinant human bone morphogenetic protein type 2 jaw reconstruction in patients affected by giant cell tumor. J Craniofac Surg 2010;1970-1975
11. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J 2011;11:471-491
12. Maiorana C, Beretta M, Battista Grossi G, et al. Histomorphometric evaluation of anorganic bovine bone coverage to reduce autogenous graft resoprtion: Preliminary results. Open Dent J 2011;5:71-78
13. Akamaru T, Suh D, Boden S, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003;28:429-434
14. Shah MM, Smyth MD, Woo AS. Adverse facial edema associated with off-label use of recombinant human bone morphogenic protein-2 in cranial reconstruction for craniosynostosis. J Neurosurg Pediatr 2008;1:255-257
15. Carreon LY, Glassman SD, Brock DC, et al. Adverse events in patients re-exposed to bone morphogenic protein for spine surgery. Spine 2008;33:391-393.